CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong · Delayed Price · Currency is HKD 15.75
+0.19 (1.22%)
Jun 18, 2026, 4:08 PM HKT
HKG:2171 Market Cap
HKG:2171 has a market cap or net worth of 9.25 billion as of June 18, 2026. Its market cap has decreased by -15.44% in one year.
Market Cap
9.25B
Enterprise Value
8.07B
Revenue
139.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.75
Market Cap Chart
Since June 18, 2021, HKG:2171's market cap has decreased from 17.02B to 9.25B, a decrease of -45.63%. That is a compound annual growth rate of -11.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 9.25B | 12.11% |
| Dec 31, 2025 | 8.25B | 63.11% |
| Dec 31, 2024 | 5.06B | 35.24% |
| Dec 29, 2023 | 3.74B | -56.36% |
| Dec 30, 2022 | 8.57B | -45.06% |
| Dec 31, 2021 | 15.61B | -8.30% |
| Jun 18, 2021 | 17.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 12.60B |
| Nanjing Leads Biolabs | 10.96B |
| GenFleet Therapeutics (Shanghai) | 10.63B |
| LongBio Pharma (Suzhou) | 10.59B |
| Ascletis Pharma | 9.93B |
| Everest Medicines | 9.54B |
| HBM Holdings | 9.18B |
| Suzhou Ribo Life Science | 8.56B |